Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Glioblastoma 7Urinary Bladder Neoplasms 5Glioma 5Prostatic Neoplasms 4Lung Neoplasms 4Esophageal Neoplasms 4Burkitt Lymphoma 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Astrocytoma 3Uterine Cervical Neoplasms 2Sarcoma, Ewing 2Sarcoma 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Mouth Neoplasms 2Mesothelioma, Malignant 2Melanoma 2Laryngeal Neoplasms 2Gliosarcoma 2Ganglioneuroblastoma 2Brain Neoplasms 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

trastuzumab deruxtecan 1tivozanib 1atezolizumab 1Specimen Handling 1Radiation 1Platinum 1Nivolumab 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Cisplatin 1CTLA-4 Antigen 1Bupropion 1Axitinib 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Radiation × 30 days × Clear all
NCT04169763 2026-05-20

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

M.D. Anderson Cancer Center

Phase 1 Recruiting
25 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡